An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.Using the National Drug Discovery Centre, researchers from the Walter and Eliza Hall Institute identified drug-like compounds that could block a key coronavirus protein called PLpro. Initially developed as potential treatments for SARS, the compounds prevented the growth of the SARS-CoV-2 virus (which causes COVID-19) in the laboratory.
- Nonlinear beam cleaning in spatiotemporally mode-locked lasers
- Stanford engineers combine light and sound to see underwater
- Business closures, partial reopenings due to COVID-19 could cost the US $3-$5 trillion i
- An escape route for seafloor methane
- Study identifies countries and states with greatest age biases